The global surgical robotic system market accounted for USD 5.06 billion in 2023 and is expected to reach USD 16.82 billion by 2034 with a CAGR of 11.54% during the forecast period 2024-2034. Government initiatives and funding support, growing geriatric population, growing demand for minimally invasive procedures, advantages of robotic-assisted surgery, and technological collaboration and partnerships will propel market expansion.
The development of next-generation surgical robotic systems has been hastened by collaboration between robotics businesses, medical device makers, and healthcare organizations. This collaboration has brought together expertise from many fields to answer clinical demands. Collaborations between academic institutions and industrial players have aided in research and development as well as given rise to chances for robotics-assisted surgery training and education. For instance, Intuitive Surgical reported in May 2024 that the FDA had cleared its Ion Endoluminal System for use in peripheral lung minimally invasive biopsies.
By component, the systems segment accounted for the highest revenue-grossing segment in the global surgical robotic system market in 2023 owing to the increasing adoption of advanced robotic-assisted surgical platforms and the demand for technologically innovative products offering enhanced precision and surgical outcomes. For instance, Johnson & Johnson subsidiary Auris Health, Inc. announced in May 2022 that the FDA had cleared their Monarch robotic surgery system. The kidney stone removal procedures can be carried out with the robot thanks to the system. The first and only multispecialty, adaptable robotic solution for bronchoscopy and urology is the Monarch robotic surgical system. Additionally, the accessories & instrument segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for specialized surgical tools and instruments compatible with surgical robotic systems, along with advancements in accessory technologies improving surgical efficiency and outcomes.
By surgery type, the urology segment accounted for the highest revenue-grossing segment in the global surgical robotic system market in 2023 owing to the increasing prevalence of urological disorders, such as prostate cancer and kidney diseases, driving the adoption of robotic-assisted procedures for improved surgical precision and patient outcomes. For instance, Medtronic launched HugoTM, an advanced robotic-assisted surgery system, in April 2024. Additionally, the neurosurgery segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for precise and minimally invasive surgical techniques, along with technological advancements in robotic systems specifically tailored for neurosurgical procedures.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global surgical robotic system market in 2023 owing to the increased adoption of robotic-assisted surgery in large hospital settings due to the benefits of improved surgical precision, shorter recovery times, and enhanced patient outcomes. For instance, Think Surgical declared in February 2024 that the country's first total knee replacement was done using their TSolution One Surgical System. Additionally, the ambulatory surgical centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend towards outpatient procedures, coupled with advancements in robotic technology enabling more complex surgeries to be performed in ambulatory surgical centers, thereby driving market growth in this segment.
North American region is anticipated to have the highest revenue share during the forecast period owing to the strong presence of key market players, high adoption rates of surgical robotic systems, and supportive healthcare infrastructure and reimbursement policies in the North American region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly increasing healthcare expenditure, growing awareness about advanced medical technologies, and expanding access to surgical robotic systems in the Asia Pacific region. For instance, Smith & Nephew announced the release of its CORITM Surgical System for orthopedic surgeries in November 2023.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
The development of next-generation surgical robotic systems has been hastened by collaboration between robotics businesses, medical device makers, and healthcare organizations. This collaboration has brought together expertise from many fields to answer clinical demands. Collaborations between academic institutions and industrial players have aided in research and development as well as given rise to chances for robotics-assisted surgery training and education. For instance, Intuitive Surgical reported in May 2024 that the FDA had cleared its Ion Endoluminal System for use in peripheral lung minimally invasive biopsies.
By component, the systems segment accounted for the highest revenue-grossing segment in the global surgical robotic system market in 2023 owing to the increasing adoption of advanced robotic-assisted surgical platforms and the demand for technologically innovative products offering enhanced precision and surgical outcomes. For instance, Johnson & Johnson subsidiary Auris Health, Inc. announced in May 2022 that the FDA had cleared their Monarch robotic surgery system. The kidney stone removal procedures can be carried out with the robot thanks to the system. The first and only multispecialty, adaptable robotic solution for bronchoscopy and urology is the Monarch robotic surgical system. Additionally, the accessories & instrument segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for specialized surgical tools and instruments compatible with surgical robotic systems, along with advancements in accessory technologies improving surgical efficiency and outcomes.
By surgery type, the urology segment accounted for the highest revenue-grossing segment in the global surgical robotic system market in 2023 owing to the increasing prevalence of urological disorders, such as prostate cancer and kidney diseases, driving the adoption of robotic-assisted procedures for improved surgical precision and patient outcomes. For instance, Medtronic launched HugoTM, an advanced robotic-assisted surgery system, in April 2024. Additionally, the neurosurgery segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for precise and minimally invasive surgical techniques, along with technological advancements in robotic systems specifically tailored for neurosurgical procedures.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global surgical robotic system market in 2023 owing to the increased adoption of robotic-assisted surgery in large hospital settings due to the benefits of improved surgical precision, shorter recovery times, and enhanced patient outcomes. For instance, Think Surgical declared in February 2024 that the country's first total knee replacement was done using their TSolution One Surgical System. Additionally, the ambulatory surgical centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend towards outpatient procedures, coupled with advancements in robotic technology enabling more complex surgeries to be performed in ambulatory surgical centers, thereby driving market growth in this segment.
North American region is anticipated to have the highest revenue share during the forecast period owing to the strong presence of key market players, high adoption rates of surgical robotic systems, and supportive healthcare infrastructure and reimbursement policies in the North American region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly increasing healthcare expenditure, growing awareness about advanced medical technologies, and expanding access to surgical robotic systems in the Asia Pacific region. For instance, Smith & Nephew announced the release of its CORITM Surgical System for orthopedic surgeries in November 2023.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Component, Surgery Type, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement
Segmentation: Surgical Robotic System Market Report 2023 - 2034
Surgical Robotic System Market Analysis & Forecast by Component 2023 - 2034 (Revenue USD Bn)
- Systems
- Accessories & Instrument
- Services
Surgical Robotic System Market Analysis & Forecast by Surgery Type 2023 - 2034 (Revenue USD Bn)
- Gynecology Surgery
- Urology Surgery
- Neurosurgery
- Orthopedic Surgery
- General Surgery
- Others
Surgical Robotic System Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Surgical Robotic System Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Surgical Robotic System Market: Component Estimates & Trend Analysis
8. Surgical Robotic System Market: Surgery Type Estimates & Trend Analysis
9. Surgical Robotic System Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Surgical Robotic System Market
12. Europe Global Surgical Robotic System Market
13. Asia Pacific Global Surgical Robotic System Market
14. Latin America Global Surgical Robotic System Market
15. MEA Global Surgical Robotic System Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Intuitive Surgical Inc.
- Medtronic plc
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- Smith & Nephew plc
- TransEnterix Surgical Inc.
- Verb Surgical Inc. (a Johnson & Johnson company)
- Auris Health Inc. (a Johnson & Johnson company)
- CMR Surgical Ltd.
- Titan Medical Inc.
- Medrobotics Corporation
- Renishaw plc
- Mazor Robotics Ltd. (a Medtronic company)
- Microbot Medical Inc.
- Think Surgical Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 5.06 Billion |
| Forecasted Market Value ( USD | $ 16.82 Billion |
| Compound Annual Growth Rate | 11.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
